Cargando…

Genomic Characterization of Acute Leukemias

Over the past two decades, hematologic malignancies have been extensively evaluated due to the introduction of powerful technologies, such as conventional karyotyping, FISH analysis, gene and microRNA expression profiling, array comparative genomic hybridization and SNP arrays, and next-generation s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiaretti, Sabina, Gianfelici, Valentina, Ceglie, Giulia, Foà, Robin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586934/ https://www.ncbi.nlm.nih.gov/pubmed/24968698 http://dx.doi.org/10.1159/000362793

Ejemplares similares

Myeloid/T-cell acute lymphoblastic leukemia in children and adults
por: Chiaretti, Sabina, et al.
Publicado: (2011)

Prognostic implications of additional genomic lesions in adult Philadelphia chromosome-positive acute lymphoblastic leukemia
por: Fedullo, Anna Lucia, et al.
Publicado: (2019)

Prognostic and therapeutic role of targetable lesions in B-lineage acute lymphoblastic leukemia without recurrent fusion genes
por: Messina, Monica, et al.
Publicado: (2016)

Comprehensive Analysis of Transcriptome Variation Uncovers Known and Novel Driver Events in T-Cell Acute Lymphoblastic Leukemia
por: Kalender Atak, Zeynep, et al.
Publicado: (2013)

Diagnosis and Subclassification of Acute Lymphoblastic Leukemia
por: Chiaretti, Sabina, et al.
Publicado: (2014)

Optimizing Molecular Minimal Residual Disease Analysis in Adult Acute Lymphoblastic Leukemia
por: Della Starza, Irene, et al.
Publicado: (2023)

Practical guidance for the management of acute lymphoblastic leukemia in the adolescent and young adult population
por: Carobolante, Francesca, et al.
Publicado: (2020)

Minimal Residual Disease in Acute Lymphoblastic Leukemia: Technical and Clinical Advances
por: Della Starza, Irene, et al.
Publicado: (2019)

Real-World Multicenter Experience in Tumor Debulking Prior to Blinatumomab Administration in Adult Patients With Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia
por: Bonifacio, Massimiliano, et al.
Publicado: (2022)

Biological Aspects of mTOR in Leukemia
por: Mirabilii, Simone, et al.
Publicado: (2018)

Acute lymphoblastic leukemia: age and biology
por: Foà, Robin
Publicado: (2011)

Real-world use of blinatumomab in adult patients with B-cell acute lymphoblastic leukemia in clinical practice: results from the NEUF study
por: Boissel, Nicolas, et al.
Publicado: (2023)

PB1711: DROPLET DIGITAL PCR DETECTION OF THE T315I BCR::ABL1 KD MUTATION IN ADULT PH-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA
por: Cardinali, Deborah, et al.
Publicado: (2023)

Long-Term Host Immune Modulation Following Tisagenlecleucel Administration in Patients with Diffuse Large B-Cell Lymphoma and B-Lineage Acute Lymphoblastic Leukemia
por: Guarini, Anna, et al.
Publicado: (2023)

Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia
por: Flex, Elisabetta, et al.
Publicado: (2008)

National Italian Delphi panel consensus: which measures are indicated to minimize pegylated-asparaginase associated toxicity during treatment of adult acute lymphoblastic leukemia?
por: Lussana, Federico, et al.
Publicado: (2020)

Case report: Ponatinib as a bridge to CAR-T cells and subsequent maintenance in a patient with relapsed/refractory Philadelphia-like acute lymphoblastic leukemia
por: Giglio, Fabio, et al.
Publicado: (2023)

Modern Management Options for Ph+ ALL
por: Ribera, Josep-Maria, et al.
Publicado: (2022)

The Role of the Microenvironment and Cell Adhesion Molecules in Chronic Lymphocytic Leukemia
por: Cerreto, Marina, et al.
Publicado: (2023)

IKAROS Deletions Dictate a Unique Gene Expression Signature in Patients with Adult B-Cell Acute Lymphoblastic Leukemia
por: Iacobucci, Ilaria, et al.
Publicado: (2012)

The deregulated expression of miR-125b in acute myeloid leukemia is dependent on the transcription factor C/EBPα
por: Vargas Romero, P, et al.
Publicado: (2015)

COVID-19 infection in acute lymphoblastic leukemia over 15 months of the pandemic. A Campus ALL report
por: Chiaretti, Sabina, et al.
Publicado: (2022)

Applicability of droplet digital polymerase chain reaction for minimal residual disease monitoring in Philadelphia‐positive acute lymphoblastic leukaemia
por: Ansuinelli, Michela, et al.
Publicado: (2021)

Daratumumab with or without chemotherapy in relapsed and refractory acute lymphoblastic leukemia. A retrospective observational Campus ALL study
por: Cerrano, Marco, et al.
Publicado: (2022)

PB1822: A CASE OF EXTRAMEDULLARY ACUTE MYELOID LEUKEMIA SUCCESSFULLY TREATED WITH NOVEL AGENTS
por: Gianfelici, V., et al.
Publicado: (2022)

Clinical relevance and treatment of nonautoimmune anemia in chronic lymphocytic leukemia
por: Molica, Stefano, et al.
Publicado: (2011)

Genetic Characterization and Risk Stratification of Acute Myeloid Leukemia
por: Pourrajab, Fatemeh, et al.
Publicado: (2020)

Proteomic Characterization of Acute Myeloid Leukemia for Precision Medicine
por: Casado, Pedro, et al.
Publicado: (2023)

A multicenter total therapy strategy for de novo adult Philadelphia chromosome positive acute lymphoblastic leukemia patients: final results of the GIMEMA LAL1509 protocol
por: Chiaretti, Sabina, et al.
Publicado: (2021)

ACUTE Lymphoblastic Leukemia (ALL) and COVID-19 Infection. a Campus ALL Report
por: Chiaretti, Sabina, et al.
Publicado: (2021)

Hematopoietic Stem Cell Transplantation in Neuromyelitis Optica-Spectrum Disorders (NMO-SD): State-of-the-Art and Future Perspectives
por: Ceglie, Giulia, et al.
Publicado: (2020)

Genome editing for sickle cell disease: still time to correct?
por: Ceglie, Giulia, et al.
Publicado: (2023)

Genomics of Hairy Cell Leukemia
por: Tiacci, Enrico, et al.
Publicado: (2017)

A Clue to Better Select Chronic Lymphocytic Leukemia Patients with Optimal Response to BNT162b2 mRNA COVID-19 Vaccine
por: Molica, Stefano, et al.
Publicado: (2021)

Management of Relapsed/Refractory All with Inotuzumab During COVID-19. A Case Report
por: Di Palma, Martina, et al.
Publicado: (2022)

Pegaspargase-modified risk-oriented program for adult acute lymphoblastic leukemia: results of the GIMEMA LAL1913 trial
por: Bassan, Renato, et al.
Publicado: (2023)

Aberrant Signaling Pathways in T-Cell Acute Lymphoblastic Leukemia
por: Bongiovanni, Deborah, et al.
Publicado: (2017)

T-Cell Acute Lymphoblastic Leukemia: Biomarkers and Their Clinical Usefulness
por: Bardelli, Valentina, et al.
Publicado: (2021)

Targeted genome editing in acute lymphoblastic leukemia: a review
por: Montaño, Adrián, et al.
Publicado: (2018)

Biologic and Therapeutic Implications of Genomic Alterations in Acute Lymphoblastic Leukemia
por: Iacobucci, Ilaria, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c0oqdgiv2gq3kpov4dmup8kacg